CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CVRx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.35+0.05 (+3.85%)
Close on Oct 19, 2026
- Market cap
- $35.80M
- P/E (TTM)
- –
- Dividend yield
- –
CVRx, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $51.88M | $47.17M | $35.11M | $18.02M | $9.15M | $1.73M | 91.6% | +10.0% |
| Germany | $4.77M | $4.13M | $3.69M | $3.48M | $3.25M | $3.79M | 8.4% | +15.6% |
| Other countries | – | $665.00K | $494.00K | $971.00K | $639.00K | $530.00K | – | – |
From the segment and revenue-disaggregation notes of CVRx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.